Literature DB >> 20337297

Three-Dimensional Features of Polypoidal Choroidal Vasculopathy Observed by Spectral-Domain OCT.

Sachi Abe, Teiko Yamamoto, Shion Haneda, Kouko Saito, Hitomi Miura, Eriko Kirii, Hidetoshi Yamashita.   

Abstract

Five eyes of five patients with polypoidal choroidal vasculopathy (PCV) without acute hemorrhagic changes or subretinal proliferative tissue to observe the three-dimensional structures and to demonstrate the nature of these images and their interpretation. The abnormal networks surrounding polypoidal lesions were considered to be abnormal pathological blood vessels. The segmentation analysis of spectral-domain optical coherence tomography (OCT) has revealed the three-dimensional features of polypoidal lesions and surrounding abnormal blood vessel networks beneath retinal pigment epithelium. The changes of pathological findings of PCV were also detected, including the enlargement of hemorrhagic pigment epithelium detachment (PED). The segmentation analysis is useful to observe PCV lesions from the bird's eye view. Copyright 2010, SLACK Incorporated.

Entities:  

Year:  2010        PMID: 20337297     DOI: 10.3928/15428877-20100215-76

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  3 in total

1.  [Sensitivity and specificity of optical coherence tomography in diagnosing polypoidal choroidal vasculopathy].

Authors:  Yi Zhang; Jing Yao; Xiao-Hua Wang; Lin Zhao; Li-Jun Wang; Jian-Ming Wang; Ai-Yi Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

2.  The noninvasive retro-mode imaging modality of confocal scanning laser ophthalmoscopy in polypoidal choroidal vasculopathy: a preliminary application.

Authors:  Renpan Zeng; Xiongze Zhang; Yu Su; Meng Li; Kunfang Wu; Feng Wen
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

Review 3.  Novel perspectives on swept-source optical coherence tomography.

Authors:  Fabio Lavinsky; Daniel Lavinsky
Journal:  Int J Retina Vitreous       Date:  2016-11-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.